innovation_redefined

CMC Biologics

CMC BiologicsCMC is a contract manufacturing organization ("CMO") of biopharmaceutical products that provides its customers with a full range of services for both mammalian cell culture and microbial fermentation processes. The company, which is based in Copenhagen, Denmark, serves customers ranging from start-ups to the largest pharmaceutical and biotech companies worldwide. MCP purchased a controlling interest in CMC in February 2008. Concurrent with MCP's investment, CMC acquired Bothell, Washington-based ICOS biologics, a CMO formerly owned by Eli Lilly & Co. This acquisition expands the company's capacity and broadens CMC's suite of offerings to its customers. 

In February 2017, CMS was sold to Asahi Glass.

Date of Investment: February 2008
 Date of Sale: February 2017
Web site: www.cmcbio.com
MCP Contact: Stephen Lehman

News: